
ImmunoProtect™: Hybridoma Sequencing
Your monoclonal antibody (mAb) is extremely valuable, but hybridoma cell lines can become unstable over time and can stop secreting antibody. With ImmunoProtect™, the DNA sequence of your antibody will be determined and can be used to express your mAb recombinantly should your hybridoma cell line become unstable.
Project Phases | Timeframe |
---|---|
I. DNA Sequencing
Phase I Deliverables
|
2 Weeks |
II. Recombinant Antibody Binding Confirmation and Test Expression
Phase II Deliverables
|
3-4 Weeks |
As with all our services, we will tailor an antibody sequencing package for your specific needs. Contact us to discuss your hybridoma health, stability or antibody secretion challenges.